Nara Organics Recalls Baby Formula After Multistate Infant Botulism Cases
Nara Organics has voluntarily recalled all whole milk powdered infant formula sold in the United States after health officials linked the product to multistate infant botulism cases, the company and regulators said.[1]
The company said the recall was coordinated with the U.S. Food and Drug Administration and that no Nara powdered formula lots have tested positive for Clostridium botulinum, but the action is a precaution.[2] All three affected infants were hospitalized with infant botulism, were successfully treated and no deaths were reported.[2] Company records show the sickened infants consumed lots 709125280E14F2, 709125288E14F2 and 708125174E14F2; the lot codes are printed on the bottom of cans.[2] Customers who bought formula from Nara.com between May and June 2026 will receive automatic refunds, and other purchasers can request refunds online or return products at Target stores.[2]
In April and May 2026, the California Department of Public Health's Infant Botulism Treatment and Prevention Program identified three toxin type A infant botulism cases in infants aged 2 to 5 months in California, Pennsylvania and Washington.[1] CDC, the FDA, California health officials and state partners investigated and the FDA notified Nara on June 12 and recommended a recall because of the epidemiological signal and the seriousness of the illnesses.[1]
The whole milk powdered formula is manufactured for sale only in the United States and is sold nationwide at Target stores, Target.com and Nara.com.[2] Some social media posts said Nara's website initially lacked a public recall notice as news of the illnesses spread.
The mainstream summary does not mention the broader context of infant botulism cases in the U.S., where the CDC typically reports 150-180 cases annually, indicating that such outbreaks are not uncommon. This statistic highlights the serious nature of the public health concern but is absent from the mainstream account, which focuses solely on the recent recall. Furthermore, the summary overlooks a prior multistate outbreak linked to another brand, ByHeart, which involved 48 confirmed or probable cases across 17 states, emphasizing that this issue is part of a troubling trend in the powdered infant formula industry. The absence of mandatory testing for Clostridium botulinum spores in infant formula, noted in FDA investigations, also suggests systemic vulnerabilities that the mainstream coverage fails to address, framing the recall as an isolated incident rather than part of a larger pattern of safety challenges in the industry.
Additionally, social media discussions reveal concerns about the initial lack of a public recall notice on Nara's website, which contrasts with the mainstream summary’s portrayal of the company's response as timely and thorough. This discrepancy raises questions about the effectiveness of communication during such critical incidents and suggests that consumers may have been left in the dark at a crucial moment. These insights underscore the need for greater transparency and vigilance in the infant formula market, which the mainstream summary does not fully capture.
Show source details & analysis (2 sources)
📊 Relevant Data
CDC surveillance data indicate 150-180 cases of infant botulism are typically reported annually in the United States.
CDC's Rapid Response Helps Solve First Infant Botulism Outbreak Linked to Formula — CDC
A prior multistate outbreak of infant botulism linked to another powdered infant formula brand (ByHeart) involved 48 confirmed or probable cases across 17 states, with all infants hospitalized and no deaths reported.
Investigation Update: Infant Botulism Outbreak, November 2025 — CDC
📌 Key Facts
- The company Nara Organics has voluntarily recalled all whole milk powdered infant formula products in coordination with the FDA and says no Nara Organics Powdered Infant Formula lots have tested positive for Clostridium botulinum, but the recall is being done as a precaution.
- All three affected infants were hospitalized with infant botulism, were successfully treated, and no deaths have been reported.
- The exact recalled lot numbers consumed by the sickened infants are 709125280E14F2, 709125288E14F2, and 708125174E14F2; lot codes are printed on the bottom of cans.
- Customers who purchased from Nara.com between May and June 2026 will receive automatic refunds; other purchasers who bought from Nara.com or Target can request refunds via the respective websites or return items in-store.
- The formula is manufactured for sale only in the United States and is sold nationwide at Target stores and on Target.com and Nara.com.
📰 Source Timeline (2)
Follow how coverage of this story developed over time
- Article specifies that the recall is a voluntary action by Nara Organics, coordinated with the FDA.
- Confirms all three affected infants were hospitalized with infant botulism but successfully treated, with no deaths reported.
- Clarifies that no Nara Organics Powdered Infant Formula lots have tested positive for Clostridium botulinum, yet the company is recalling all whole milk powdered infant formula products as a precaution.
- Provides exact recalled lot numbers consumed by the sickened infants: 709125280E14F2, 709125288E14F2, and 708125174E14F2, and notes the lot codes are printed on the bottom of cans.
- Details refund logistics: customers who purchased from Nara.com between May and June 2026 will receive automatic refunds; others who bought from Nara.com or Target can request or obtain refunds via the respective websites or in-store returns.
- Restates that the formula is manufactured for sale only in the United States and is sold nationwide at Target stores and on Target.com and Nara.com.